Combining minimally invasive glaucoma surgery with pharmaceutical drug delivery is an option to lower IOP in patients who are ...

Lead epigenetic restoration therapy enters the clinic for glaucoma and NAION, targeting a root cause of age-related vision ...

Glaucoma is the leading cause of irreversible blindness in the world. Only cataracts, which are reversible surgically, are a greater cause of blindness. Diabetic retinopathy, a disease of the nerve in ...

A US biotechnology company has tested a gene therapy designed to reverse ageing in humans for the first time. View on ...

(Siarhei_Fetisenkov/Creatas Video+/Getty Images Plus) An eagerly awaited and controversial clinical trial to 'wind back the ...

Life Biosciences announced on Tuesday that the first participant in its phase 1 clinical trial has received a dose of a novel ...

ViaLase Inc. today announced the completion of the first commercial procedures using its noninvasive laser treatment for open-angle glaucoma.

Treatment of glaucoma is directed towards controlling intraocular pressure (IOP) and the options are many, starting from medical therapy to cyclodestructive surgeries. Drainage devices are a treatment ...

The June 2024 warrants are only held by investors who participated in the June 2024 financing, or who bought the warrants on ...

BEDFORD, Mass., June 04, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today ...